211 related articles for article (PubMed ID: 10910097)
21. Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors.
Hines SJ; Litz JS; Krystal GW
Breast Cancer Res Treat; 1999 Nov; 58(1):1-10. PubMed ID: 10634512
[TBL] [Abstract][Full Text] [Related]
22. Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit.
Lennartsson J; Shivakrupa R; Linnekin D
J Biol Chem; 2004 Oct; 279(43):44544-53. PubMed ID: 15308671
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase C-δ-mediated recycling of active KIT in colon cancer.
Park M; Kim WK; Song M; Park M; Kim H; Nam HJ; Baek SH; Kim H
Clin Cancer Res; 2013 Sep; 19(18):4961-71. PubMed ID: 23881925
[TBL] [Abstract][Full Text] [Related]
24. Pp60c-src mediates ERK activation/nuclear localization and PAI-1 gene expression in response to cellular deformation.
Samarakoon R; Higgins PJ
J Cell Physiol; 2003 Jun; 195(3):411-20. PubMed ID: 12704650
[TBL] [Abstract][Full Text] [Related]
25. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; RaschellĂ G; Dominici C
Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
[TBL] [Abstract][Full Text] [Related]
26. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
27. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
[TBL] [Abstract][Full Text] [Related]
28. Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells.
Litz J; Krystal GW
Mol Cancer Ther; 2006 Jun; 5(6):1415-22. PubMed ID: 16818499
[TBL] [Abstract][Full Text] [Related]
29. Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase.
Fuertes MB; Molinero LL; Toscano MA; Ilarregui JM; Rubinstein N; Fainboim L; Zwirner NW; Rabinovich GA
Mol Cell Biochem; 2004 Dec; 267(1-2):177-85. PubMed ID: 15663199
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
Mahabeleshwar GH; Das R; Kundu GC
J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
[TBL] [Abstract][Full Text] [Related]
31. Role of nonreceptor protein tyrosine kinases during phospholipase C-gamma 1-related uterine contractions in the rat.
Phillippe M; Sweet LM; Bradley DF; Engle D
Reprod Sci; 2009 Mar; 16(3):265-73. PubMed ID: 19208792
[TBL] [Abstract][Full Text] [Related]
32. Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells.
Suyama H; Igishi T; Ueda Y; Shigeoka Y; Kodani M; Morita M; Takeda K; Sumikawa T; Nakazaki H; Matsunami K; Matsumoto S; Shimizu E
Oncol Rep; 2010 Jan; 23(1):217-22. PubMed ID: 19956885
[TBL] [Abstract][Full Text] [Related]
33. Involvement of PI3-kinase and its association with c-Src in PTH-stimulated rat enterocytes.
Gentili C; Morelli S; Russo De Boland A
J Cell Biochem; 2002; 86(4):773-83. PubMed ID: 12210743
[TBL] [Abstract][Full Text] [Related]
34. Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling.
Bayle J; Letard S; Frank R; Dubreuil P; De Sepulveda P
J Biol Chem; 2004 Mar; 279(13):12249-59. PubMed ID: 14707129
[TBL] [Abstract][Full Text] [Related]
35. Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancer.
Maulik G; Bharti A; Khan E; Broderick RJ; Kijima T; Salgia R
J Environ Pathol Toxicol Oncol; 2004; 23(4):237-51. PubMed ID: 15511212
[TBL] [Abstract][Full Text] [Related]
36. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.
Timokhina I; Kissel H; Stella G; Besmer P
EMBO J; 1998 Nov; 17(21):6250-62. PubMed ID: 9799234
[TBL] [Abstract][Full Text] [Related]
37. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
38. Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells.
Shivakrupa R; Linnekin D
Cell Signal; 2005 Jan; 17(1):103-9. PubMed ID: 15451030
[TBL] [Abstract][Full Text] [Related]
39. Stem cell factor/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia.
Feng LX; Ravindranath N; Dym M
J Biol Chem; 2000 Aug; 275(33):25572-6. PubMed ID: 10849422
[TBL] [Abstract][Full Text] [Related]
40. E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition.
Matsui J; Yamamoto Y; Funahashi Y; Tsuruoka A; Watanabe T; Wakabayashi T; Uenaka T; Asada M
Int J Cancer; 2008 Feb; 122(3):664-71. PubMed ID: 17943726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
